Skip to main content
HUMASIS CO., LTD. logo

HUMASIS CO., LTD. — Investor Relations & Filings

Ticker · 205470 ISIN · KR7205470008 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2021-03-05 Proxy Solicitation & In…
Country KR South Korea
Listing KO 205470

About HUMASIS CO., LTD.

https://www.humasis.com/en/

Humasis Co., Ltd. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) devices, with a primary focus on Point-of-Care Testing (POCT). The company develops and produces a range of rapid diagnostic solutions, including immunodiagnostic kits for the early screening of various diseases, compact instruments for quantitative analysis, and personal health care products. A key operational strength is the in-house development and production of critical bio-materials, such as diagnostic immune antigens, which ensures the consistent performance and accuracy of its products. Humasis aims to provide technologies for precise and rapid disease analysis to support clinical decision-making and promote individual health management.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Humasis Co., Ltd. It contains the meeting agenda, date, location, and detailed management information including board activity, remuneration, and financial statements (balance sheets and income statements) for the purpose of shareholder review prior to the meeting. This document is a standard proxy statement/information circular provided to shareholders to solicit votes for the upcoming AGM.
2021-03-05 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Statement), which is a formal document used by a company to request that shareholders grant them proxy voting rights for an upcoming General Meeting. It contains details about the meeting date, agenda items (such as approval of financial statements, director/auditor remuneration, and amendments to retirement regulations), and instructions for voting. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2021-03-03 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Humasis, detailing the date, location, and agenda items (such as approval of financial statements and director compensation). This document serves as the official proxy solicitation and information statement provided to shareholders prior to the meeting, which aligns with the PSI (Proxy Solicitation & Information Statement) category.
2021-03-02 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Humasis) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for material financial changes. Since it provides key financial highlights and performance metrics rather than a full annual report or a simple announcement of a report's availability, it falls under the category of an Earnings Release (ER), which covers initial announcements of financial results. FY 2020
2021-02-04 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure from Humasis regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) for COVID-19 antigen diagnostic kits. In the context of Korean regulatory filings (DART), this is a standard material contract disclosure. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-01-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (closing of the shareholder register) for Humasis. It specifies the record date, the period of suspension, and the reason (preparation for the 7th Annual General Meeting). Since it is a brief regulatory notice regarding corporate administrative procedures rather than a full report or a specific financial filing, it falls under the general regulatory filing category.
2020-12-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.